Novo Nordisk
NVO
#33
Rank
ยฃ214.15 B
Marketcap
ยฃ48.49
Share price
-6.78%
Change (1 day)
-50.56%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Market capitalization of Novo Nordisk (NVO)

Market cap: ยฃ214.15 Billion

As of April 2025 Novo Nordisk has a market cap of ยฃ214.15 Billion. This makes Novo Nordisk the world's 33th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Novo Nordisk from 1996 to 2025

End of year Market Cap

Year Marketcap Change
2025ยฃ214.15 B-30.02%
2024ยฃ306.04 B-15.46%
2023ยฃ362.01 B43.83%
2022ยฃ251.69 B33.2%
2021ยฃ188.96 B57.95%
2020ยฃ119.63 B12.76%
2019ยฃ106.09 B20.45%
2018ยฃ88.08 B-9.22%
2017ยฃ97.02 B27.13%
2016ยฃ76.32 B-25.74%
2015ยฃ102.77 B42.07%
2014ยฃ72.33 B17.92%
2013ยฃ61.34 B9%
2012ยฃ56.28 B31.14%
2011ยฃ42.91 B-1.91%
2010ยฃ43.75 B74.9%
2009ยฃ25.01 B12.53%
2008ยฃ22.23 B5.24%
2007ยฃ21.12 B55.95%
2006ยฃ13.54 B28.21%
2005ยฃ10.56 B12.55%
2004ยฃ9.38 B18.72%
2003ยฃ7.90 B25.99%
2002ยฃ6.27 B-34.55%
2001ยฃ9.58 B15.77%
2000ยฃ8.28 B45.99%
1999ยฃ5.67 B-2.15%
1998ยฃ5.79 B-12%
1997ยฃ6.58 B60.88%
1996ยฃ4.09 B

End of Day market cap according to different sources

On Apr 4th, 2025 the market cap of Novo Nordisk was reported to be:

ยฃ214.15 Billion
by Yahoo Finance info icon info icon
ยฃ214.15 Billion
by CompaniesMarketCap info icon info icon
ยฃ216.35 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ยฃ100.98 B-52.84%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ513.87 B 139.95%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ87.22 B-59.27%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ98.64 B-53.94%๐Ÿ‡ซ๐Ÿ‡ท France